Product Details
| Product Name: Everolimus | CAS No.: 159351-69-6 |
| Min. Order: 1KG | Purity: 99 |
| Supply Ability: 999 | Release date: 2020/11/16 |
Everolimus is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works similarly to sirolimus as an inhibitor of mammalian target of rapamycin
It is currently used as an immunosuppressant to prevent rejection of organ transplants and treatment of renal cell cancer and other tumours. Much research has also been conducted on everolimus and other mTOR inhibitors as targeted therapy for use in a number of cancers.
Inhibition of mTOR, the molecular target of Everolimus, extends the lifespan of model organisms including mice, and mTOR inhibition has been suggested as an anti-aging therapy.
Product Name: Everolimus
CAS RN.: 159351-69-6
EINECS: Add
Molecular Weight: 958.2244
Molecular Formula: C53H83NO14
Density: 1.18g/cm3
Boiling Point(ºC): 998.7°C at 760 mmHg
Flash Point(ºC): 557.8°C
refractive_index: 1.548
Company Profile Introduction
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
|
VIP2Y
|
Xi an Biohorlden Industry Trade Co Ltd
|
2026-06-26 | ||
|
VIP6Y
|
RongNa Biotechnology Co.,Ltd
|
2026-06-26 | ||
|
VIP6Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2026-06-26 | ||
|
VIP5Y
|
Sinoway Industrial co., ltd.
|
2026-06-22 | ||
|
VIP3Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2026-06-12 | ||
|
VIP1Y
|
Jinan Ruitong Biotech Co., Ltd.
|
2026-06-08 | ||
| $389.00 |
VIP6Y
|
Baoji Guokang Healthchem Co., Ltd.
|
2026-05-15 | |
| $37.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-04-21 | |
| $5.00 |
Wuhan JiyunZen Tech Co., Ltd.
|
2026-04-10 | ||
| $1.10 |
VIP6Y
|
Dideu Industries Group Limited
|
2025-11-18 |
- Since: 2019-10-11
- Address: Room 201, 11 Xinhouying Road, Xicheng Lian, Xinluo District, Longyan City, Fujian Province, China

China